Breast Imaging: Page 74

Breast MRI improves survival rates for at-risk women
By Kate Madden Yee
Breast MRI's sensitivity is superior to that of mammography in long-term screening for women at risk of breast cancer, according to a new study in the Journal of Clinical Oncology. What's more, the study showed that breast MRI improved survival rates by almost 20% when compared to women tracked in earlier research.
November 16, 2010
Interactive breast ultrasound CAD improves lesion characterization
By Erik L. Ridley
Tuesday, November 30 | 11:10 a.m.-11:20 a.m. | SSG01-05 | Room E450AIn this Tuesday scientific session, a Canadian research team will share details on why computer-aided detection (CAD) can be a useful adjunctive tool for interpreting breast ultrasound studies.
November 14, 2010
Targeted ultrasound best for biopsy after incidental breast MRI findings
By Kate Madden Yee
Wednesday, December 1 | 3:10 p.m.-3:20 p.m. | SSM02-02 | Room E450ABreast MRI can find additional lesions when used as an adjunct to mammography and ultrasound, but it's also associated with a higher false-positive rate, according to Italian researchers. Using targeted ultrasound with these incidental MRI lesions offers a way to reduce false positives.
November 11, 2010
Interactive breast ultrasound CAD improves lesion characterization
By Erik L. Ridley
Tuesday, November 30 | 11:10 a.m.-11:20 a.m. | SSG01-05 | Room E450AIn this paper presentation, a Canadian research team will share details on why computer-aided detection (CAD) can be a useful adjunctive tool for interpreting breast ultrasound studies.
November 11, 2010
DBT improves sensitivity, specificity of mammography
By Kate Madden Yee
Thursday, December 2 | 10:40 a.m.-10:50 a.m. | SSQ01-02 | Arie Crown TheaterDigital breast tomosynthesis (DBT) reduces the problem of tissue superimposition, thus improving both the sensitivity and specificity of mammography in diagnosis and screening, according to researchers from King's College Hospital in London.
November 9, 2010
Targeted ultrasound best for biopsy after incidental breast MRI findings
By Kate Madden Yee
Wednesday, December 1 | 3:10 p.m.-3:20 p.m. | SSM02-02 | Room E450ABreast MRI can find additional lesions when used as an adjunct to mammography and ultrasound, but it's also associated with a higher false-positive rate, according to Italian researchers. Using targeted ultrasound with these incidental MRI lesions offers a way to reduce false positives.
November 9, 2010
DBT equivalent to FFDM for cancer detection
By Kate Madden Yee
Wednesday, December 1 | 10:25 a.m.-10:35 a.m. | VB41-08 | Arie Crown TheaterDigital breast tomosynthesis (DBT) finds and identifies breast cancers just as well as full-field digital mammography (FFDM), according to a study to be presented on Wednesday by researchers from Albert Einstein Medical Center in Philadelphia.
November 9, 2010
Community facilities follow breast MRI rules
By AuntMinnie.com staff writers
An overwhelming majority of facilities in the Breast Cancer Surveillance Consortium (BCSC) performing breast MRI in the U.S. are compliant with technical guidelines for use of the modality, according to a study in the November issue of the Journal of the American College of Radiology.
October 31, 2010
U.K. DBT trial set to commence
By AuntMinnie.com staff writers
Researchers in the U.K. are preparing to launch a 1.6 million pound ($2.6 million U.S.) trial to determine the efficacy of digital breast tomosynthesis (DBT) to screen for breast cancer.
October 31, 2010
Norwegian researcher launches DBT study
By AuntMinnie.com staff writers
A Norwegian researcher has launched a study that will compare the performance of digital breast tomosynthesis (DBT) to conventional digital mammography, according to a Norwegian hospital.
October 3, 2010
FDA panel gives nod to Hologic tomosynthesis PMA
By AuntMinnie.com staff writers
An advisory panel of the U.S. Food and Drug Administration has unanimously approved a premarket approval (PMA) application from Hologic for a digital breast tomosynthesis (DBT) system. If the FDA signs off on the final PMA, Hologic will be the first vendor to sell a DBT system on the U.S. market.
September 23, 2010
FDA panel to review Hologic tomo unit
By AuntMinnie.com staff writers
An advisory panel of the U.S. Food and Drug Administration on September 24 is scheduled to review a regulatory application from Hologic for a 3D digital breast tomosynthesis mammography system.
September 22, 2010
Previous Page
Page 74 of 87
Next Page